Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
Date:3/26/2009

SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the company's corporate overview on Thursday, April 2, 2009 at 9:00am Eastern Time (6:00am Pacific Time) during the BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its product candidate for the treatment of acute pain and fever. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contacts:  William R. LaRue
               SVP, CFO
               Cadence Pharmaceuticals, Inc.
               858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
2. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
8. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
9. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
11. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
(Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
(Date:7/24/2014)... As part of the long-term strategic approach, ... region during 2014 with potential global expansion. , "We ... DZS to manage our clinical trials globally and in ... R&D and President of SBI pharmaceuticals MENA, Dr. Riyadh ... a focus on utilizing eClinical software and flexible team ...
Breaking Biology Technology:Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
... 2011 Abaxis, Inc. (Nasdaq: ABAX ), ... for the medical, research and veterinary markets, announced today ... APS, ("SMB"), a privately-held developer and manufacturer of point-of-care ... based in Copenhagen, Denmark, has been the original equipment ...
... DIEGO, Feb. 10, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... year ended December 31, 2010. For the fourth ... or $0.05 per basic share, compared with a net loss of ... in 2009. For the year ended December 31, 2010, the Company ...
... - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), ... portfolio of promising hematology and cancer-related products at various ... for the second quarter of fiscal 2011, ended December ... Hematology Annual Meeting in December 2010, we presented interim ...
Cached Biology Technology:Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 2Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 3Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS 4Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 2Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 3Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 4Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 5Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 6Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results 7YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 2YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 3YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 4YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 5YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 6YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 7YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 8YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results 9
(Date:7/24/2014)... biodiversity and one of the most species richness biome ... However, current levels of diversity might be still underestimated. ... in the description of new endemic species of this ... availability of samples for DNA analysis. , Using ... morphological analysis, researchers from the University of Richmond ...
(Date:7/24/2014)... life arose have been maintained in our cells today according ... published today in the Journal of Biological Chemistry ... in animals still perform ancient reactions thought to have been ... years ago. , The primordial soup theory suggests that life ... the combination of metals, gases from the atmosphere and some ...
(Date:7/24/2014)... This news release is available in German . ... much welcomed in Norway and they are a common sight ... so that electric cars topped the list of new vehicle ... to the situation in Germany, where electric vehicles claim only ... cars on the roads in Germany, only a mere 8000 ...
Breaking Biology News(10 mins):A tiny new species of frog from Brazil with a heroic name 2Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3
... ropes are used by kids for fun and by athletes ... jump ropes work? Can important engineering principles be studied? ... built themselves a robotic jump rope device that controls all ... length, and the distance between "hands." They capture the motion ...
... November 21, 2010 -- Airplanes do not look much like ... bird or a very strange plane -- but should they? ... California and South Africa inadvertently answered recently when they set ... order to make airplanes more fuel efficient. The modern ...
... 2010 -- From a baby,s first blurted "bowl!," for the ... the capacity for complex vocalizations is one of humankind,s most ... most of our lives. Not so for people ... who suffer the social stigma of affected speech. Nor so ...
Cached Biology News:Should airplanes look like birds? 2Air flows in mechanical device reveal secrets of speech pathology 2
ANTI CORTIS BIN GLOB...
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
ANTI S. ENTERID LPS...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
Biology Products: